- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05348902
Locked-in Syndrome Caused by Pulmonary Arteriovenous Malformation: A Case Report
April 26, 2022 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
In this case, we report a case of atresia syndrome (LIS), a serious neurological disease caused by pulmonary arteriovenous fistula (PAVM).
We present a previously healthy middle-aged woman who developed atresia syndrome after severe pontine infarction due to basilar artery occlusion due to undiagnosed arteriovenous malformation.
This report reviewed the medical history, post-admission examination and related literature, and concluded that PAVM should be considered as the cause of implicit stroke, especially in young patients with right-to-left shunt, and should be actively treated.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Anticipated)
1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: hao wang, master
- Phone Number: +8615968891667
- Email: 2519160@zju.edu.cn
Study Contact Backup
- Name: le zhang, master
- Phone Number: +8613616511229
- Email: 2319053@zju.edu.cn
Study Locations
-
-
-
Hangzhou, China
- Recruiting
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China
-
Contact:
- hao wang, master
- Phone Number: +86 15968891667
- Email: 2519160@zju.edu.cn
-
Contact:
- le zhang, master
- Phone Number: +86 13616511229
- Email: 2319053@zju.edu.cn
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
A patient with locked-in syndrome
Description
Inclusion Criteria:
- A case of Locked-in syndrome due to pulmonary arteriovenous malformation
Exclusion Criteria:
- Patients or family members objected to the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Locked-in syndrome caused by pulmonary arteriovenous malformation . Check list report
Time Frame: 1month
|
A recommendation is made for the treatment and prognosis of patients with severe atresia caused by arteriovenous fistula.
|
1month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 1, 2021
Primary Completion (ANTICIPATED)
June 2, 2022
Study Completion (ANTICIPATED)
June 2, 2022
Study Registration Dates
First Submitted
April 10, 2022
First Submitted That Met QC Criteria
April 26, 2022
First Posted (ACTUAL)
April 27, 2022
Study Record Updates
Last Update Posted (ACTUAL)
April 27, 2022
Last Update Submitted That Met QC Criteria
April 26, 2022
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Cardiovascular Diseases
- Vascular Diseases
- Nervous System Diseases
- Neoplasms by Histologic Type
- Neoplasms
- Neurologic Manifestations
- Disease
- Neuromuscular Diseases
- Pathological Conditions, Anatomical
- Cardiovascular Abnormalities
- Neoplasms, Vascular Tissue
- Vascular Malformations
- Paralysis
- Vascular Fistula
- Fistula
- Syndrome
- Congenital Abnormalities
- Hemangioma
- Arteriovenous Malformations
- Quadriplegia
- Arteriovenous Fistula
- Locked-In Syndrome
Other Study ID Numbers
- 2022-0138
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Locked-In Syndrome;Pulmonary Arteriovenous Malformation
-
Sohag UniversityNot yet recruiting
-
Okami Medical, Inc.Enrolling by invitationHemorrhage | Pulmonary Arteriovenous Malformation | Arterial Bleed | EmbolizationUnited States
-
University Hospital TuebingenUnknown
-
Tomislav MilekovicUniversity Hospital, Geneva; Centre Hospitalier Universitaire Vaudois; Wyss Center... and other collaboratorsTerminatedHealthy | Tetraplegia | Locked-in SyndromeSwitzerland
-
Oregon Health and Science UniversityCompletedCerebral Palsy | Physical Impairments | Cerebral Ataxia | locked-in SyndromeUnited States
-
Zhujiang HospitalNot yet recruitingLocked in Syndrome
-
King's College Hospital NHS TrustKing's College LondonCompletedCongenital Disorders | Pulmonary Arteriovenous MalformationUnited Kingdom
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityCompletedProbable Capillary Malformation-Arteriovenous Malformation SyndromeChina
-
Johns Hopkins UniversityUMC Utrecht; National Institute on Deafness and Other Communication Disorders...WithdrawnLocked-in SyndromeUnited States
-
National Cancer Institute (NCI)RecruitingNoonan Syndrome | Legius Syndrome | Cardiofaciocutaneous Syndrome | Costello Syndrome | Capillary Arteriovenous Malformation Syndrome | RASopathyUnited States
Clinical Trials on In this study, only cases were collected and reported without any intervention or adverse reactions
-
Medipol UniversityCompletedDiabetes Mellitus | Postural Control | Diabetes and Risk of Diabetic Foot Ulcer | Plantar Pressure DistrubutionTurkey (Türkiye)